Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
---|
Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
---|
Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
---|
Merit Medical Systems (NASDAQ:MMSI) reported its Q4 earnings results on Wednesday, February 28, 2024 at 04:05 PM.
Here's what investors need to know about the announcement.
Merit Medical Systems beat estimated earnings by 7.000000000000001%, reporting an EPS of $0.81 versus an estimate of $0.76.
Revenue was up $31.10 million from the same period last year.
Last quarter the company beat on EPS by $0.1 which was followed by a 9.0% increase in the share price the next day.
Here's a look at Merit Medical Systems's past performance:
Quarter | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
---|---|---|---|---|
EPS Estimate | 0.65 | 0.75 | 0.55 | 0.67 |
EPS Actual | 0.75 | 0.81 | 0.64 | 0.79 |
Revenue Estimate | 306.27M | 310.45M | 280.45M | 290.16M |
Revenue Actual | 315.23M | 320.06M | 297.56M | 293.42M |
To track all earnings releases for Merit Medical Systems visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: MMSI